Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cytometix
Milwaukee, Wisconsin, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
As of the last available information, Cytometix had raised $1.9 million to advance a novel small molecule pain therapeutic toward an IND filing and potential Phase 1 trials. The company also had an asthma drug candidate in earlier development. No clinical results have been published or reported.
- Therapeutic areas
- PulmonologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Partnerships
Collaboration with Medical College of Wisconsin for preclinical research and scientific consulting support
Beyond the preview
Go deeper on Cytometix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytometix.